Scinai Immunotherapeutics (NASDAQ:SCNI – Get Free Report) and Athira Pharma (NASDAQ:ATHA – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations and dividends. Analyst Recommendations This is a breakdown of […]
Scinai Immunotherapeutics (SCNI) & Its Competitors Head to Head Review themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ The influenza vaccine market is expected to grow by USD 2.93 billion from 2022 to 2027. In addition, the momentum of the market will progress.
StockNews.com began coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Free Report) in a report issued on Monday morning. The firm issued a hold rating on the stock. BiondVax Pharmaceuticals Price Performance BiondVax Pharmaceuticals has a fifty-two week low of $1.25 and a fifty-two week high of $11.80. The stock has a 50-day simple moving […]
StockNews.com assumed coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Free Report) in a research report report published on Sunday. The firm issued a hold rating on the stock. BiondVax Pharmaceuticals Stock Performance The company has a market capitalization of $2.54 million, a price-to-earnings ratio of -0.53 and a beta of 2.37. BiondVax Pharmaceuticals has […]